Skip to main content
B

Biosphere

Biosphere designs modern, UV-enabled bioreactors to lower the capital intensity of industrial biomanufacturing. This approach eliminates the need for traditional steam sterilization, resulting in simpler, cheaper, and more performant production systems. The company enables rapid scale-up for next-generation bioproducts like therapeutics, enzymes, and sustainable fuels.

Oakland, United States12700+ followers
Updated 2 months ago

Funding

$13.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

LCVC
Funding rounds are not available yet.

Founders

Founder details are not available yet.

Product

Problem

Traditional biomanufacturing relies on steam-in-place sterilization, necessitating complex and expensive stainless-steel bioreactors with extensive piping and valve systems. This reliance on outdated technology increases the capital intensity and complexity of scaling bioproduct production.

Solution

Biosphere offers a UV-enabled bioreactor platform that reduces the capital expenditure required for biomanufacturing. By replacing steam sterilization with a UV sterilize-in-place protocol, Biosphere's bioreactors can utilize cheaper materials and a simplified design with fewer valves and pipes. This approach enables faster sterilization protocols and reduces the risk associated with scaling up production of bioproducts, including therapeutics, enzymes, proteins, and bioplastics. The UV sterilization process ensures reliable sterility, allowing for a new generation of low-cost, high-performance biomanufacturing hardware.

Target Audience

Biosphere targets companies in the bioproducts industry, including those producing therapeutics, enzymes, proteins, bioplastics, fertilizers, and jet fuel, seeking to scale production with reduced capital intensity.

Features

  • UV sterilize-in-place protocol for aseptic environments
  • Compatibility with cheaper bioreactor materials
  • Reduced valve and pipe count compared to traditional steam-based systems (33% reduction)
  • Faster sterilization protocols (6x faster)
  • Reliable sterilization, tested to 100% effectiveness against spore contamination
This profile is AI-generated and may contain inaccuracies.